Pacifico National, Inc. dba AmEx Pharmacy recalls
FDA enforcement reports naming Pacifico National, Inc. dba AmEx Pharmacy as the recalling firm.
- Recall reports
- 5
- Class I (serious)
- 2
- Most recent report
- Sep 18, 2019
- Sep 18, 2019Bevacizumab, 2Drug · Pacifico National, Inc. dba AmEx PharmacyLack of assurance of sterility.Class II
- Sep 18, 2019Bevacizumab, 1Drug · Pacifico National, Inc. dba AmEx PharmacyLack of assurance of sterility.Class II
- May 8, 2019BEVACIZUMAB 1Drug · Pacifico National, Inc. dba AmEx PharmacyDefective Delivery System: difficult to expressClass II
- Jun 1, 2016Avastin (Bevacizumab) 2 mg/0Drug · Pacifico National, Inc. dba AmEx PharmacyNon-Sterility: Product tested positive for bacterial contamination.Class I
- Jun 1, 2016Avastin (Bevacizumab) 1Drug · Pacifico National, Inc. dba AmEx PharmacyNon-Sterility: Product tested positive for bacterial contamination.Class I